EarlySense was an Israeli medical device company with offices in the United States. It has sold its proprietary contact-free continuous monitoring technology to Hill-Rom, now Baxter International.

EarlySense
Company typePrivate
IndustryMedical Technology
Founded2004
FoundersDr. Danny Lange, Yossi Gross, Avner Halperin
Headquarters
Area served
Worldwide
Key people
Matt Johnson (CEO)
Websiteearlysense.com

History edit

The company was founded in 2004 by Dr. Danny Lange, Yossi Gross, and Avner Halperin. The CEO is Matt Johnson.[1]

The product has two components: a sensor that is placed under a mattress and a software application.[2] The company sells a version of the product designed for use in hospitals that received 510K marketing clearance from the FDA in 2009, meaning that it is equivalent to devices already on the market.[3][4][2] It also received the CE mark in Europe.[3] In this system, the sensor measures changes in pressure applied to it through the mattress, and transmits the measurements to the software, which converts them to heart rate, breathing rate, and motion. The application can be used by nurses to monitor patients in their ward remotely; it can provide alerts if patients try to get out of bed, and can provide alerts that a patient needs to be turned in order to avoid the development of pressure ulcers.[2]

In September 2015 the company launched a version of the product for people to use at home to monitor their sleep; in this system the desktop application is replaced by a smartphone app.[5] EarlySense also provided OEM services to other companies that market the system under their own brands.[6]

The company also offers contact-free continuous monitoring (CFCM) sensors for use in healthcare settings. The sensors allow wireless monitoring of patients.[1]

See also edit

References edit

  1. ^ a b "EarlySense brings hospital care to the wireless era. Finally!". The Jerusalem Post | JPost.com. Retrieved 2020-08-27.
  2. ^ a b c Helfand, M; Christensen, V; Anderson, J (2011). "Technology Assessment: Early Sense for Monitoring Vital Signs in Hospitalized Patients". PMID 27606394. {{cite journal}}: Cite journal requires |journal= (help)
  3. ^ a b "EarlySense patient monitor system gets FDA marketing nod - Globes English". Globes (in Hebrew). 8 June 2009.
  4. ^ Ford, Omar (September 24, 2012). "EarlySense gives clinicians heads up in deteriorating vitals". Medical Device Daily.
  5. ^ Wasserman, Emily (September 2, 2015). "EarlySense moves patient monitoring tech to at-home setting". FierceBiotech.
  6. ^ Comstock, Jonah (2 September 2015). "EarlySense, Samsung unveil direct-to-consumer, contact-free sleep monitor". MobiHealthNews.